SCM
ELEV

Sio Capital Management’s Elevation Oncology ELEV Stock Holding History

Sio Capital Management’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-876,611
Closed -$1.67M – 51
2023
Q1 		$1.67M Buy
876,611
+516,880
+144% +$667K 0.82% 23
2022
Q4 		$342K Hold
359,731
– – 0.13% 40
2022
Q3 		$406K Hold
359,731
– – 0.13% 39
2022
Q2 		$504K Hold
359,731
– – 0.19% 50
2022
Q1 		$907K Buy
359,731
+109,731
+44% +$440K 0.3% 50
2021
Q4 		$1.5M Buy
+250,000
New +$1.73M 0.45% 47

Other funds holding ELEV

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Sio Capital Management's ELEV Position: Q2 2023 in Review

Sio Capital Management sold out of Elevation Oncology (ELEV) in Q2 2023, closing a stake of 876,611 shares — an estimated $1.67M sold.

Sio Capital Management first reported a position in ELEV in Q4 2021 and held it in 6 quarters. The position peaked at $1.67M in Q1 2023. 39 funds tracked by Wall St. Rank hold ELEV as of Q2 2023.

  • Sio Capital Management reported no remaining Elevation Oncology position as of Q2 2023 after selling out during the quarter.
  • Sio Capital Management sold 876,611 Elevation Oncology shares in Q2 2023, an estimated $1.67M.
  • Sio Capital Management first reported a position in Elevation Oncology in Q4 2021 and held it in 6 quarters.
  • Sio Capital Management's Elevation Oncology position peaked at $1.67M in Q1 2023.
  • 39 funds tracked by Wall St. Rank held Elevation Oncology as of Q2 2023.

Based on Sio Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.